Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity

Although circulating tumour DNA (ctDNA) can predict immune checkpoint blockade (ICB) responses, its association with tumour biomarkers remains unknown. Here, the authors use ctDNA to inform exome and transcriptome profiling of >100 patients with 30 cancer types on a single clinical ICB trial and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: S. Y. Cindy Yang, Scott C. Lien, Ben X. Wang, Derek L. Clouthier, Youstina Hanna, Iulia Cirlan, Kelsey Zhu, Jeffrey P. Bruce, Samah El Ghamrasni, Marco A. J. Iafolla, Marc Oliva, Aaron R. Hansen, Anna Spreafico, Philippe L. Bedard, Stephanie Lheureux, Albiruni Razak, Vanessa Speers, Hal K. Berman, Alexey Aleshin, Benjamin Haibe-Kains, David G. Brooks, Tracy L. McGaha, Marcus O. Butler, Scott V. Bratman, Pamela S. Ohashi, Lillian L. Siu, Trevor J. Pugh
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/2a55653c8f4a4ed888f461e4bdb5696f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2a55653c8f4a4ed888f461e4bdb5696f
record_format dspace
spelling oai:doaj.org-article:2a55653c8f4a4ed888f461e4bdb5696f2021-12-02T18:53:20ZPan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity10.1038/s41467-021-25432-72041-1723https://doaj.org/article/2a55653c8f4a4ed888f461e4bdb5696f2021-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25432-7https://doaj.org/toc/2041-1723Although circulating tumour DNA (ctDNA) can predict immune checkpoint blockade (ICB) responses, its association with tumour biomarkers remains unknown. Here, the authors use ctDNA to inform exome and transcriptome profiling of >100 patients with 30 cancer types on a single clinical ICB trial and identify tumour microenvironment features associated with response.S. Y. Cindy YangScott C. LienBen X. WangDerek L. ClouthierYoustina HannaIulia CirlanKelsey ZhuJeffrey P. BruceSamah El GhamrasniMarco A. J. IafollaMarc OlivaAaron R. HansenAnna SpreaficoPhilippe L. BedardStephanie LheureuxAlbiruni RazakVanessa SpeersHal K. BermanAlexey AleshinBenjamin Haibe-KainsDavid G. BrooksTracy L. McGahaMarcus O. ButlerScott V. BratmanPamela S. OhashiLillian L. SiuTrevor J. PughNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
S. Y. Cindy Yang
Scott C. Lien
Ben X. Wang
Derek L. Clouthier
Youstina Hanna
Iulia Cirlan
Kelsey Zhu
Jeffrey P. Bruce
Samah El Ghamrasni
Marco A. J. Iafolla
Marc Oliva
Aaron R. Hansen
Anna Spreafico
Philippe L. Bedard
Stephanie Lheureux
Albiruni Razak
Vanessa Speers
Hal K. Berman
Alexey Aleshin
Benjamin Haibe-Kains
David G. Brooks
Tracy L. McGaha
Marcus O. Butler
Scott V. Bratman
Pamela S. Ohashi
Lillian L. Siu
Trevor J. Pugh
Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
description Although circulating tumour DNA (ctDNA) can predict immune checkpoint blockade (ICB) responses, its association with tumour biomarkers remains unknown. Here, the authors use ctDNA to inform exome and transcriptome profiling of >100 patients with 30 cancer types on a single clinical ICB trial and identify tumour microenvironment features associated with response.
format article
author S. Y. Cindy Yang
Scott C. Lien
Ben X. Wang
Derek L. Clouthier
Youstina Hanna
Iulia Cirlan
Kelsey Zhu
Jeffrey P. Bruce
Samah El Ghamrasni
Marco A. J. Iafolla
Marc Oliva
Aaron R. Hansen
Anna Spreafico
Philippe L. Bedard
Stephanie Lheureux
Albiruni Razak
Vanessa Speers
Hal K. Berman
Alexey Aleshin
Benjamin Haibe-Kains
David G. Brooks
Tracy L. McGaha
Marcus O. Butler
Scott V. Bratman
Pamela S. Ohashi
Lillian L. Siu
Trevor J. Pugh
author_facet S. Y. Cindy Yang
Scott C. Lien
Ben X. Wang
Derek L. Clouthier
Youstina Hanna
Iulia Cirlan
Kelsey Zhu
Jeffrey P. Bruce
Samah El Ghamrasni
Marco A. J. Iafolla
Marc Oliva
Aaron R. Hansen
Anna Spreafico
Philippe L. Bedard
Stephanie Lheureux
Albiruni Razak
Vanessa Speers
Hal K. Berman
Alexey Aleshin
Benjamin Haibe-Kains
David G. Brooks
Tracy L. McGaha
Marcus O. Butler
Scott V. Bratman
Pamela S. Ohashi
Lillian L. Siu
Trevor J. Pugh
author_sort S. Y. Cindy Yang
title Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
title_short Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
title_full Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
title_fullStr Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
title_full_unstemmed Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
title_sort pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/2a55653c8f4a4ed888f461e4bdb5696f
work_keys_str_mv AT sycindyyang pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT scottclien pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT benxwang pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT dereklclouthier pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT youstinahanna pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT iuliacirlan pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT kelseyzhu pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT jeffreypbruce pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT samahelghamrasni pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT marcoajiafolla pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT marcoliva pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT aaronrhansen pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT annaspreafico pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT philippelbedard pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT stephanielheureux pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT albirunirazak pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT vanessaspeers pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT halkberman pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT alexeyaleshin pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT benjaminhaibekains pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT davidgbrooks pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT tracylmcgaha pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT marcusobutler pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT scottvbratman pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT pamelasohashi pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT lillianlsiu pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
AT trevorjpugh pancanceranalysisoflongitudinalmetastatictumorsrevealsgenomicalterationsandimmunelandscapedynamicsassociatedwithpembrolizumabsensitivity
_version_ 1718377317024137216